News

Manto uses UN meeting to call for ARV monitoring

Written by Health-e News

SA NGOs condemn statements made by former health minister at UN session of the Commission on the Status of Women looking at caregiving in the context of HIV/AIDS

Former health minister Manto Tshabalala-Msimang used an international platform to agitate for better monitoring of HIV/AIDS medication, squandering an opportunity for South Africa to work with the United Nations and its member countries.

This is according to Sonke Gender Justice Network and People Opposed to Women Abuse (POWA) which attended the UN 53rd session on the Commission on the Status of Women (CSW) held in New York recently.

The theme of the meeting was ‘€œThe equal sharing of responsibilities between women and men, including caregiving in the context of HIV and AIDS’€.

 ‘€œThe UN CSW offers an opportunity for South Africa to work with UN agencies, civil society and other UN signatory countries to seek bold solutions to prevention and treatment efforts and thereby reducing the burden of AIDS-related care,’€ said Sonke and POWA.

‘€œSadly, the pronouncements made on behalf of the South African government delegation to the 2009 UN CSW by Tshabalala Msimang, now the Minister in the Presidency, have once again undermined South Africa’€™s credibility in the international community and stand in stark contradiction to the priorities laid out in the National Strategic Plan for HIV/AIDS,’€ they added.

Instead of focusing on how to reach the HIV/AIDS caregiving targets in the new plan, including providing treatment, care and support to 80 percent of HIV positive people and their families by 2011, Tshabalala-Msimang steered discussion to alternative and traditional HIV/AIDS remedies and the need for drug monitoring.

Her official address did not mention the new strategic plan once, but instead appealed to ‘€œdevelopment partners’€  for more resources for ‘€œresearch on affordable alternatives such as complementary and traditional medicines, as well as nutrition’€.

‘€œWe are particularly concerned about inadequate drug surveillance and pharmacovigilance capacity, especially in the African region. We therefore call upon our development partners to assist,’€ said Tshabalala-Msimang.

She repeated these views in a number of other presentations.

 ‘€œWhen senior government representatives imply that anti-retroviral therapies are not safe they sow confusion and compromise our efforts to ensure that people access and adhere to treatment,’€ said Sonke and POWA.

About the author

Health-e News

Health-e News is South Africa's dedicated health news service and home to OurHealth citizen journalism. Follow us on Twitter @HealtheNews